BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24987782)

  • 1. [Technology and disciplinary fields: cytotechnicians and implementation of the Pap test in Brazil].
    Teixeira LA; Pumar L
    Dynamis; 2014; 34(1):49-72, 6. PubMed ID: 24987782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Im perfect tools for a difficult job: colposcopy, 'colpocytology' and screening for cervical cancer in Brazil.
    Teixeira LA; Löwy I
    Soc Stud Sci; 2011 Aug; 41(4):585-608. PubMed ID: 21998969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of the Papanicolaou smear.
    Tambouret RH
    Clin Obstet Gynecol; 2013 Mar; 56(1):3-9. PubMed ID: 23314726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making the Pap smear into the "right tool" for the job.
    Casper MJ; Clarke AE
    Soc Stud Sci; 1998 Apr; 28(2):255-90. PubMed ID: 11620085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pap test: George N. Papanicolaou (1883-1962). A screening test for the prevention of cancer of uterine cervix.
    Michalas SP
    Eur J Obstet Gynecol Reprod Biol; 2000 Jun; 90(2):135-8. PubMed ID: 10825631
    [No Abstract]   [Full Text] [Related]  

  • 6. George Papanicolaou (1883-1962): Discoverer of the Pap smear.
    Tan SY; Tatsumura Y
    Singapore Med J; 2015 Oct; 56(10):586-7. PubMed ID: 26512152
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical cytology screening in Vietnamese asylum seekers in a Hong Kong detention center. Population demographics and historical perspectives.
    Chang AR; Sewell H
    Acta Cytol; 2002; 46(3):475-80. PubMed ID: 12040640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dr. George Papanicolaou and the birth of the Pap test.
    Vilos GA
    Obstet Gynecol Surv; 1999 Aug; 54(8):481-3. PubMed ID: 10434271
    [No Abstract]   [Full Text] [Related]  

  • 9. The history of the Papanicolaou smear and the odyssey of George and Andromache Papanicolaou.
    Vilos GA
    Obstet Gynecol; 1998 Mar; 91(3):479-83. PubMed ID: 9491881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution.
    Gharoro EP; Ikeanyi EN
    Int J Gynecol Cancer; 2006; 16(3):1063-8. PubMed ID: 16803486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of eliminating cervical cancer in the United States: a story of politics, prudishness, and prevention.
    Fisher JW; Brundage SI
    Women Health; 2009; 49(2-3):246-61. PubMed ID: 19533513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [History of the development of screening tests for cervical cancer].
    Herrera YA; Piña-Sánchez P
    Rev Med Inst Mex Seguro Soc; 2015; 53(6):670-7. PubMed ID: 26506482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. George Papanicolaou.
    Kyle RA; Shampo MA
    JAMA; 1983 Dec; 250(21):2934. PubMed ID: 6358551
    [No Abstract]   [Full Text] [Related]  

  • 15. Low uptake of Pap smear testing among medical clinic attendees in a tertiary care hospital in Sri Lanka.
    Shivanthan MC; Arunakiri K; Wickramasinghe SI; Sumanasekera RD; Jayasinghe S; Rajapakse S
    Int Health; 2014 Jun; 6(2):138-43. PubMed ID: 24737803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
    Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inequalities in Pap smear screening for cervical cancer in Brazil.
    Martínez-Mesa J; Werutsky G; Campani RB; Wehrmeister FC; Barrios CH
    Prev Med; 2013 Oct; 57(4):366-71. PubMed ID: 23827721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the Role of Training Health Volunteers in Promoting Pap Smear Test Use among Iranian Women Based on the Protection Motivation Theory.
    Ghahremani L; Harami ZK; Kaveh MH; Keshavarzi S
    Asian Pac J Cancer Prev; 2016; 17(3):1157-62. PubMed ID: 27039741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pap test and Bethesda 2014.
    Nayar R; Wilbur DC
    Cancer Cytopathol; 2015 May; 123(5):271-81. PubMed ID: 25931431
    [No Abstract]   [Full Text] [Related]  

  • 20. Viva Mulher: constructing a cervical cancer control program in Brazil.
    Porto MA; Habib PA
    Dynamis; 2014; 34(1):101-23. PubMed ID: 24987783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.